Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 3Unspecified Childhood Solid Tumor, Protocol Specific 1Sarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Fatigue 1Familial ependymoma 1Central Nervous System Neoplasms 1

Interventions

Irinotecan 3Cyclophosphamide 3temsirolimus 2Sirolimus 2sargramostim 1reolysin 1irofulven 1etoposide phosphate 1cixutumumab 1aflibercept 1Tirapazamine 1Temozolomide 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Genetic Testing 1Gene Expression Profiling 1Gemcitabine 1Gefitinib 1Flow Cytometry 1Filgrastim 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cisplatin 1Carboplatin 1Busulfan 1Bortezomib 1Bevacizumab 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Unspecified Childhood Solid Tumor, Protocol Specific × Mass Spectrometry × Clear all
NCT00900354 2013-08-12

Pharmacokinetics of Dactinomycin in Young Patients With Cancer

National Cancer Institute (NCI)

Unknown
50 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡